Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
Central Nervous System (CNS) Biomarkers: Technologies and Global Markets
Report Includes
- An up-to-date overview and analysis of the global market for central nervous system (CNS) biomarkers
- In-depth analysis of global market trends, featuring historical revenue data for 2024, estimated figures for 2025, as well as forecasts for 2030. This analysis includes projections of compound annual growth rates (CAGRs) through 2030
- Analysis of market opportunities with a holistic review of Porter’s five forces model and industry supply chain analysis considering both micro- and macro environmental factors prevailing in the market
- Explanation of market drivers, restraints and other forces impacting the global market
- Description of technologies such as genomics, proteomics, and imaging, and assessments of their advantages and disadvantages.
- Discussion of CNS disease segments, prevalence, and gaps in treatment for Alzheimer’s disease, depression, Parkinson’s disease, multiple sclerosis, and others
- Coverage of evolving technologies, the current and future market potential, R&D activities, growth strategies, regulatory framework and reimbursement scenarios, and ESG trends of the market
- Identification of companies best positioned to meet this demand owing to their proprietary technologies, mergers and acquisitions, joint ventures and other strategic alliances
- Descriptive company profiles of the leading global players
